MAPT and amyloidosis: Indeed, the in vitro profile of CHDI-626 suggests its potential as an mHTT PET radioligand in humans [16], particularly due to its lack of affinity towards amyloid plaques and/or tau tangles, as previously observed in human tissue with other mHTT-directed radioligands [15, 17].